Getinge AB (publ)

OM:GETI B Stock Report

Market Cap: SEK 53.0b

Getinge Valuation

Is GETI B undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of GETI B when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: GETI B (SEK194.5) is trading below our estimate of fair value (SEK391.1)

Significantly Below Fair Value: GETI B is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for GETI B?

Other financial metrics that can be useful for relative valuation.

GETI B key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.8x
Enterprise Value/EBITDA11.7x
PEG Ratio1.7x

Price to Earnings Ratio vs Peers

How does GETI B's PE Ratio compare to its peers?

The above table shows the PE ratio for GETI B vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average46.1x
EKTA B Elekta
18.5x14.4%SEK 24.1b
ARJO B Arjo
21.1x18.6%SEK 10.8b
CEVI CellaVision
40.4x24.1%SEK 5.9b
ELOS B Elos Medtech
104.3xn/aSEK 5.7b
GETI B Getinge
20.5x12.0%SEK 53.0b

Price-To-Earnings vs Peers: GETI B is good value based on its Price-To-Earnings Ratio (20.5x) compared to the peer average (46.1x).

Price to Earnings Ratio vs Industry

How does GETI B's PE Ratio compare vs other companies in the European Medical Equipment Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a24.7%
 n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a24.7%
 n/an/an/a
No more companies

Price-To-Earnings vs Industry: GETI B is good value based on its Price-To-Earnings Ratio (20.5x) compared to the European Medical Equipment industry average (29.4x).

Price to Earnings Ratio vs Fair Ratio

What is GETI B's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

GETI B PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio20.5x
Fair PE Ratio24.8x

Price-To-Earnings vs Fair Ratio: GETI B is good value based on its Price-To-Earnings Ratio (20.5x) compared to the estimated Fair Price-To-Earnings Ratio (24.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst GETI B forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentSEK 194.50
SEK 230.00
+18.3%
14.2%SEK 300.00SEK 190.00n/a8
Jul ’25SEK 181.45
SEK 225.44
+24.2%
15.8%SEK 290.00SEK 165.00n/a9
Jun ’25SEK 187.00
SEK 229.22
+22.6%
13.2%SEK 300.00SEK 186.00n/a9
May ’25SEK 235.00
SEK 235.50
+0.2%
12.2%SEK 300.00SEK 186.00n/a10
Apr ’25SEK 215.40
SEK 226.10
+5.0%
14.9%SEK 300.00SEK 164.00n/a10
Mar ’25SEK 206.90
SEK 227.10
+9.8%
15.2%SEK 300.00SEK 164.00n/a10
Feb ’25SEK 197.00
SEK 236.60
+20.1%
11.3%SEK 300.00SEK 210.00n/a10
Jan ’25SEK 224.30
SEK 228.56
+1.9%
12.8%SEK 300.00SEK 190.00n/a9
Dec ’24SEK 226.70
SEK 220.33
-2.8%
17.4%SEK 300.00SEK 150.00n/a9
Nov ’24SEK 202.50
SEK 210.89
+4.1%
14.7%SEK 250.00SEK 150.00n/a9
Oct ’24SEK 192.70
SEK 203.11
+5.4%
16.1%SEK 250.00SEK 134.00n/a9
Sep ’24SEK 190.60
SEK 203.11
+6.6%
16.1%SEK 250.00SEK 134.00n/a9
Aug ’24SEK 198.70
SEK 203.11
+2.2%
16.1%SEK 250.00SEK 134.00SEK 202.609
Jul ’24SEK 188.95
SEK 230.40
+21.9%
19.9%SEK 300.00SEK 139.00SEK 181.4510
Jun ’24SEK 251.30
SEK 265.30
+5.6%
11.8%SEK 300.00SEK 193.00SEK 187.0010
May ’24SEK 259.90
SEK 260.33
+0.2%
11.6%SEK 295.00SEK 193.00SEK 235.009
Apr ’24SEK 252.70
SEK 252.89
+0.07%
8.6%SEK 285.00SEK 208.00SEK 215.409
Mar ’24SEK 218.30
SEK 253.44
+16.1%
8.1%SEK 285.00SEK 208.00SEK 206.909
Feb ’24SEK 239.40
SEK 252.89
+5.6%
7.9%SEK 285.00SEK 208.00SEK 197.009
Jan ’24SEK 216.30
SEK 264.33
+22.2%
5.5%SEK 285.00SEK 240.00SEK 224.309
Dec ’23SEK 245.50
SEK 274.89
+12.0%
5.4%SEK 300.00SEK 250.00SEK 226.709
Nov ’23SEK 226.80
SEK 273.63
+20.6%
5.5%SEK 300.00SEK 250.00SEK 202.508
Oct ’23SEK 191.70
SEK 292.50
+52.6%
8.6%SEK 331.00SEK 250.00SEK 192.706
Sep ’23SEK 196.95
SEK 323.33
+64.2%
14.1%SEK 370.00SEK 250.00SEK 190.606
Aug ’23SEK 225.10
SEK 323.33
+43.6%
14.1%SEK 370.00SEK 250.00SEK 198.706

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.